Media release

SHPA taking action on Closing the Gap and the Voice to Parliament

On Closing The Gap Day 2023, SHPA reiterates its call for action to reduce longstanding inequity in medicines access for Aboriginal and Torres Strait Islander patients receiving Pharmaceutical Benefits Scheme (PBS) medicines from hospitals, and formally declared its support for a First Nations Voice to Parliament.


View   

With the patient at the centre, PharmCare 2023 opens

Australia’s newest conference for accredited, onsite aged care and GP pharmacists leading patient centred care is underway, and the SHPA Accredited Pharmacist Directory is now live, as delegates from across healthcare disciplines attending the opening of PharmCare 2023 in Hobart.


View   

Hospital pharmacists support pholcodine recall

SHPA has supported the announcement by the Therapeutic Goods Administration (TGA) to recall pholcodine-containing medicines and remove them from the Australian Register of Therapeutic Goods (ARTG), as a regulatory decision that will improve patient safety and reduce medication-related harm.


View   

Hospital expertise can drive pharmacist scope reform

SHPA has welcomed the release of the Strengthening Medicare Taskforce Report, while reiterating that hospital-led expansion of pharmacists’ scope of practice is key to reforming and transforming Australia’s healthcare systems for greater sustainability and improved patient outcomes.


View   

Deprescribing, antimicrobial monitoring and Closing the Gap call lead latest JPPR

The dynamism of Hospital Pharmacy is on display in the latest issue of the Journal of Pharmacy Practice and Research (JPPR) with research including validation of an international approach to pharmacist-led deprescribing in kidney disease and the challenges of antimicrobial surveillance in smaller, regional, and remote health facilities, as well as a call to the profession as Hospital Pharmacists unite to Close the Gap.


View